Beta-cell defence and repair mechanisms in human pancreatic islets

Hormone and Metabolic Research

Volumn 28, Issue 6, 1996, Pages 302-305

  Eizirik, D L ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

beta cell repair; catalase; HSP; IDDM; NO; superoxide dismutase

Indexed keywords

CATALASE; HEAT SHOCK PROTEIN 70; SUPEROXIDE DISMUTASE;

AEROBIC METABOLISM; CONFERENCE PAPER; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PRIORITY JOURNAL;

RODENTIA;

EID: 0029950062     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979799     Document Type: Conference Paper

References (44)

1. Bedoya, F. J., M. Flodström, D. L Eizirik: Pyrrolidine dithiocarbamate prevents IL-1 induced nitric oxide synthease mRNA, but not superoxide dismutase mRNA, in insulin-producing cells. Biochem. Biophys. Res. Commun. 210: 816-822 (1995)
2. Bellman K., A. Wenz, J. Radons, V. Burkart, R. Kleemann, H. Kolb: Heat shock induces resistance in rat pancreatic islets against nitric oxide, oxygen radicals and streptozotocin toxicity in vitro. J. Clin. Invest. 95: 2840-2845 (1995)
3. Bigdeli, N., A. Niemann, S. Sandler, D. L Eizirik: Dissociation between interleukin-1β-induced expression of mRNA for superoxide dismutase and nitric oxide synthase in insulin-producing cells. Biochem. Biophys. Res. Commun. 203: 1542-1547 (1994)
4. Borg, L A. H., E. Cagliero, S. Sandler, N. Welsh, D. L. Eizirik: Interleukin-1β increases the activity of superoxide dismutase in rat pancreatic islets. Endocrinology 130: 2851-2857 (1992)
5. Castano, L., G. S. Eisenbarth: Type-1 diabetes: a chronic autoimmune disease of human, mouse and rat. Annu. Rev. Immunol. 8: 647-679 (1991)
6. Cetkovic-Cvrlje, M., D. L Eizirik: TNF-α and IFN-γ potentiates the deleterious effects of IL-1β on mouse pancreatic islets mainly via generation of nitric oxide. Cytokine 6: 399-406 (1994)
7. Corbett, J. A., M. A. Sweetland, J. L. Wang, J. R. Lancaster Jr., M. L. McDaniel: Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc. Natl. Acad. Sci. USA 90: 1731 - 1735 (1993)
8. Delaney, C. A., D. L. Eizirik, J. E. Lowe, M. HJ. L. Green, J. R. Thorpe, D. G. Pipeleers, C. Hellerström, I. C. Green: Effects of nitric oxide on DNA damage and ultrastructure in islets of Langerhans - a comparison of human and rodent. Diabetologia (in press, 1995) (abstract)
9. Delaney, C. A., M. H. L Green, J. E. Lowe, I. C. Green: Endogenous nitric oxide induced by interleukin-1β in rat islets of Langerhans and HIT-T15 cells causes significant DNA damage as measured by the "comet" assay. FEBS Lett. 333: 291-295 (1993)
10. Eizirik, D. L., G. E. Kisby: Cycad toxin-induced damage of rodent and human pancreatic β-cells. Biochem. Pharmacol. 50: 355-365 (1995)
11. Eizirik, D. L., G. S. Korbutt, C. Hellerström: Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the β-cell function. J. Clin. Invest. 90: 1263-1268 (1992)
12. Eizirik, D. L., F. Lejerstam: The inducible form of nitric oxide synthase (iNOS) in insulin-producing cells. Diabete Metab. 20: 116-122 (1994)
13. Eizirik, D. L., R. H. Migliorini: Reduced diabetogenic effect of streptozotocin in rats previously adapted to a high-protein carbohydrate-free diet. Diabetes 33: 383-388 (1984)
14. Eizirik, D. L., D. G. Pipeleers, Z. Ling, N. Welsh, C. Hellerström, A. Andersson: Major species differences between humans and rodents in the susceptibility to pancreatic β-cell injury. Proc. Natl. Acad. Sci. USA 91: 9253-9256 (1994)
15. Eizirik, D. L., S. Sandler: Function and metabolism of pancreatic B-cells maintained in culture following experimentally induced damage. Pharmacol. Toxicol. 65: 163-168 (1989)
16. Eizirik, D. L., S. Sandler, J. Palmer: Repair of pancreatic β-cells. A relevant phenomenon in early IDDM? Diabetes 42: 1383-1391 (1993)
17. Eizirik, D. L., S. Sandler, N. Welsh, K. Bendtzen, C. Hellerström: Nicotinamide decreases nitric oxide production and partially protects human panreatic islets against the suppressive effects of combination sof cytokines. Autoimmunity 19: 193-198 (1994)
18. Eizirik, D. L., S. Sandler, N. Welsh, M. Cetkovic-Cvrlje, A. Nieman, D. A. Geller, D. G. Pipeleers, K. Bendtzen, C. Hellerström: Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J. Clin. Invest. 93: 1968-1974 (1994)
19. Eizirik, D. L., N. Welsh, C. Hellerström: Predominance of stimulatory effects of interleukin-1β on isolated huma pancreatic islets. J. Clin. Endocrinol. Metab. 76: 399-403 (1993)
20. Eizirik, D. L., M. Welsh, E. Strnadell, N. Welsh, S. Sandler: Interleukin-1β depletes insulin messenger ribonucleic acid and increases the heat shock rotein hsp70 in mouse pancreatic islets without impairing the glucose metabolism. Endocrinology 127: 2290-2297 (1990)
21. Fehsel, K., A. Jalowy, S. Qi, V. Burkart, B. Hartmann, H. Kolb: Islet cell DNA is a target of inflammatory attack by nitric oxide. Diabetes 42: 496-500 (1993)
22. Grankvist, K., S. Marklund, I.-B. Täljedal: CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. Biochem. J. 199: 393-398 (1981)
23. Helqvist, S., B. S. Polla, J. Johannensen, J. Nerup: Heat shock protein induction in rat pancreatic islets by human recombinant interleukin-1β. Diabetologia 34: 150-156 (1991)
24. Jansson, L., D. L. Eizirik, D. G. Pipeleers, L. A. H. Borg, C. Hellerström, A. Andersson: Impairment of glucose-induced insulin secretion in human pancreatic islets transplanted to diabetic nude mice. J. Clin. Invest. 96: 721 -726 (1995)
25. Kato, H., M. Harada, K. Tsuchiya, K. Moriwaki: Absence of correlation between DNA repair in ultraviolet irradiated mammalian cells and life span of the donor species. Japan J. Genetics 55: 99-108 (1980)
26. Kawahara, D. J., J. S. Kenney: Species differences in human and rat islet sensitivity to human cytokines. Monoclonal anti-interleukin-1 (IL-1) influences on direct and indirect IL-1-mediated islet effects. Cytokine 3: 117-124 (1991)
27. Malaisse, W. J., F. Malaisse-Lagae, A. Sener, D. G. Pipeleers: Determinants of the selective toxicity of alloxan to the pancreatic β-cell. Proc. Natl. Acad. Sci. USA 79: 827-830 (1982)
28. Mandrup-Poulsen, T., S. Helqvist, L. D. Wogensen, J. Mølvig, F. Pociot, J. Johannensen, J. Nerup: Cytokines and free radicals as effector molecules in the dstruction of pancreatic β-cells. Curr. Top. Microbiol. Immunol. 164: 169-193 (1990)
29. Margulis, B. A., S. Sandler, D. L. Eizirik, N. Welsh, M. Welsh: Liposomal delivery of purified heat shock protein hsp70 into rat pancreatic islets as protection against interleukin-1β-induced impaired β-cell function. Diabetes 40: 1418-1422 (1991)
30. Pipeleers, D., M. Van de Winkel: Pancreatic B cell spossess defense mechanisms against cell-specific toxicity. Proc. Natl. Acad. Sci. USA 83: 5267-5271 (1986)
31. Rabinovitch, A.: Roles of cytokine sin IDDM pathogenesis and islet β-cell destruction. Diabetes Rev. 1: 215-240 (1993)
32. Rabinovitch, A., W. L. Suarez-Pinzon, K. Strynadka, R. Schulz, J. R. T. Lakey, G. L. Warnock, R. V. Rajotte: Human pancreatic islet β-cell destruction by cytokines is indepenent of nitric oxide production. J. Clin. Endocrinol. Metab. 79: 1058-1062 (1994)
33. Rerup, C. C.: Drugs producing diabetes through damage of hte insulin secreting cells. Phrmacol. Rev. 22: 485-518 (1970)
34. Sandler, S., D. L. Eizirik: Culture of human pancreatic islets. In: Method in Molecular Biology - Human Cell Culture Protocols. G. E. Jones (ed.), Humana Press Inc., Totowa, NJ (in press)
35. Sandler, S., D. L. Eizirik, C. Svensson, E. Strandell, M. Welsh, N. Welsh: Biochemical and molecular action sof interleukin-1 on pancreatic β-cells. Autoimmunity 10: 241-253 (1991)
36. Strandell, E., D. L. Eizirik, S. Sandler: Reversal of β-cell supression in vitro in pancreatic islets isolated from nonobese diabetic mice during the phase preceding insulin-dependent diabetes mellitus. J. Clin. Invest. 85: 1944-1950 (1990)
37. Strandell, E., S. Sandler, C. Boitard, D. L. Eizirik: Role of infiltrating T cells for impaired glucose metabolism in pancreatic islets isolated from non-obese diabetic mice. Diabetologia 35: 924-931 (1992)
38. Schuit, F.: Major differences between human and rat beta cells in glucose transporter gene expression. Diabetologia (in press, 1995) (abstract)
39. Tuch, B. E., J. R. Turtle, C. J. Simeonovic: Streptozotocin is not toxic to the human fetal B cell. Diabetologia 32: 678-684 (1989)
40. Welch, M. J.: Mammalian stress response: cell physiology, structure/function of stress proteins, and implications for medicine and disease. Physiol. Rev. 72: 1063-1081 (1992)
41. Welsh, M., D. L. Eizirik, E. Strandell: Heat shock treatment of mouse pancreatic islets results in partial loss of islet cells but no remaining functional impairment among surviving β-cells. J. Mol. Endocrinol. 1: 27-31 (1988)
42. Welsh, N., B. Margulis, K. Bendtzen, S. Sandler: Liposomal delivery of antioxidant enzymes protects against hydrogen peroxide- but not interleukin-1β-induced inhibition of glucose metabolism in rat pancreatic islets. J. Endocrinol. 143: 151-156 (1994)
43. Welsh, N., B. Margulis, H. Borg, H. J. Wiklund, J. Saldeen, M. Flodström, M. A. Mello, A. Andersson, D. G. Pipeleers, C. Hellerström, D. L. Eizirik: Differential expression of heat shock proteins and antioxidant enzymes in isolated human and rodent pancreatic islets. Mol. Med. (in press, 1995)
44. Zhou, Y.-P., V. Grill: Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans. J. Clin. Endocrinol. Metab. 80: 1584-1590 (1995)